Paper30952976
O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.
Barkovskaya A and 5 others. Sci Rep, 2019. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes. Papers, record 30952976. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30952976
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| N-Acetylglucosaminyltransferases | Major topic |
| Triple Negative Breast Neoplasms | Major topic |
| Apoptosis | |
| Cell Cycle Checkpoints | |
| Cell Line, Tumor | |
| DNA Damage | |
| Female | |
| Humans | |
| Transcription Factor HES-1 | |
| Up-Regulation |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA016672 | NCI NIH HHS | United States | P30CA016672 | PubMed and NIH | NIH RePORTER |
| R01 GM094263 | NIGMS NIH HHS | United States | R01GM094263 | PubMed and NIH | NIH RePORTER |
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21840999 | Hyperglycemia-induced O-GlcNAcylation and truncation of 4E-BP1 protein in liver of a mouse model of type 1 diabetes. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21840999 | PubMed |
| 2 | 16964247 | Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. | Nat Cell Biol | 2006 | https://conductscience.org/library/papers/16964247 | PubMed |
| 3 | 25636967 | mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer. | Mol Cancer Res | 2015 | https://conductscience.org/library/papers/25636967 | PubMed |
| 4 | 29496446 | Notch1 regulates PTEN expression to exacerbate renal tubulointerstitial fibrosis in diabetic nephropathy by inhibiting autophagy via interactions with Hes1. | Biochem Biophys Res Commun | 2018 | https://conductscience.org/library/papers/29496446 | PubMed |
| 5 | 29127647 | O-GlcNAcylation in women's cancers: breast, endometrial and ovarian. | J Bioenerg Biomembr | 2018 | https://conductscience.org/library/papers/29127647 | PubMed |
| 6 | 21760855 | Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis. | Horm Cancer | 2011 | https://conductscience.org/library/papers/21760855 | PubMed |
| 7 | 26614871 | Ribosomal Protein S6 Phosphorylation: Four Decades of Research. | Int Rev Cell Mol Biol | 2015 | https://conductscience.org/library/papers/26614871 | PubMed |
| 8 | 28408472 | The sweet side of the cell cycle. | Biochem Soc Trans | 2017 | https://conductscience.org/library/papers/28408472 | PubMed |
| 9 | 27458206 | OGT restrains the expansion of DNA damage signaling. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/27458206 | PubMed |
| 10 | 8999954 | A subpopulation of estrogen receptors are modified by O-linked N-acetylglucosamine. | J Biol Chem | 1997 | https://conductscience.org/library/papers/8999954 | PubMed |
| 11 | 18398844 | How basal are triple-negative breast cancers? | Int J Cancer | 2008 | https://conductscience.org/library/papers/18398844 | PubMed |
| 12 | 29556333 | Upregulation of HES1 Promotes Cell Proliferation and Invasion in Breast Cancer as a Prognosis Marker and Therapy Target via the AKT Pathway and EMT Process. | J Cancer | 2018 | https://conductscience.org/library/papers/29556333 | PubMed |
| 13 | 18550849 | HES1 is a novel interactor of the Fanconi anemia core complex. | Blood | 2008 | https://conductscience.org/library/papers/18550849 | PubMed |
| 14 | 20190804 | Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. | Oncogene | 2010 | https://conductscience.org/library/papers/20190804 | PubMed |
| 15 | 12101391 | Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. | Apoptosis | 2002 | https://conductscience.org/library/papers/12101391 | PubMed |
| 16 | 22234518 | Molecular insights on basal-like breast cancer. | Breast Cancer Res Treat | 2012 | https://conductscience.org/library/papers/22234518 | PubMed |
| 17 | 9218810 | Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k. | EMBO J | 1997 | https://conductscience.org/library/papers/9218810 | PubMed |
| 18 | 21176168 | PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. | Cell Commun Signal | 2010 | https://conductscience.org/library/papers/21176168 | PubMed |
| 19 | 28929346 | O-GlcNAc-Dependent Regulation of Progesterone Receptor Function in Breast Cancer. | Horm Cancer | 2018 | https://conductscience.org/library/papers/28929346 | PubMed |
| 20 | 23935944 | O-GlcNAcylation-inducing treatments inhibit estrogen receptor α expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells. | PLoS One | 2013 | https://conductscience.org/library/papers/23935944 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42120876 | Identification and quantification of intracellular N-acetylglucosamine modified glycoRNAs. | Nat Commun | 2026 | https://conductscience.org/library/papers/42120876 | PubMed |
| 40824482 | Cell cycle regulation in cancer cells by O-GlcNAcylation. | Glycoconj J | 2025 | https://conductscience.org/library/papers/40824482 | PubMed |
| 40392313 | HES1 in cancer: a key player in tumorigenesis and its prognostic significance. | Mol Genet Genomics | 2025 | https://conductscience.org/library/papers/40392313 | PubMed |
| 40128346 | O-GlcNAcylation on serine 40 of histone H2A promotes proliferation and invasion in triple-negative breast cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/40128346 | PubMed |
| 39413067 | The correlation between cellular O-GlcNAcylation and sensitivity to O-GlcNAc inhibitor in colorectal cancer cells. | PLoS One | 2024 | https://conductscience.org/library/papers/39413067 | PubMed |
| 39337387 | O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39337387 | PubMed |
| 38642246 | Breast cancer therapy: from the perspective of glucose metabolism and glycosylation. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/38642246 | PubMed |
| 37231419 | Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer. | Cancer Cell Int | 2023 | https://conductscience.org/library/papers/37231419 | PubMed |
| 36291918 | The Emerging Roles of Protein Interactions with O-GlcNAc Cycling Enzymes in Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36291918 | PubMed |
| 36059648 | Targeting O-GlcNAcylation to overcome resistance to anti-cancer therapies. | Front Oncol | 2022 | https://conductscience.org/library/papers/36059648 | PubMed |
| 36039850 | Suppression of Ca2+ signaling enhances melanoma progression. | EMBO J | 2022 | https://conductscience.org/library/papers/36039850 | PubMed |
| 35216622 | Unconventional protein post-translational modifications: the helmsmen in breast cancer. | Cell Biosci | 2022 | https://conductscience.org/library/papers/35216622 | PubMed |
| 34014546 | Diabetes and Cancer: The Epidemiological and Metabolic Associations. | Adv Exp Med Biol | 2021 | https://conductscience.org/library/papers/34014546 | PubMed |
| 33669699 | Role of Selected miRNAs as Diagnostic and Prognostic Biomarkers in Cardiovascular Diseases, Including Coronary Artery Disease, Myocardial Infarction and Atherosclerosis. | J Cardiovasc Dev Dis | 2021 | https://conductscience.org/library/papers/33669699 | PubMed |
| 33669256 | Overview of the Assays to Probe O-Linked β-N-Acetylglucosamine Transferase Binding and Activity. | Molecules | 2021 | https://conductscience.org/library/papers/33669256 | PubMed |
| 33159661 | O-GlcNAcylation: the "stress and nutrition receptor" in cell stress response. | Cell Stress Chaperones | 2021 | https://conductscience.org/library/papers/33159661 | PubMed |
| 33046784 | Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells. | Sci Rep | 2020 | https://conductscience.org/library/papers/33046784 | PubMed |
| 32611550 | Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9. | Mol Cancer Res | 2020 | https://conductscience.org/library/papers/32611550 | PubMed |
| 31813458 | The Metabolic Interplay between Cancer and Other Diseases. | Trends Cancer | 2019 | https://conductscience.org/library/papers/31813458 | PubMed |
| 31426393 | Epigenetic Dysregulation at the Crossroad of Women's Cancer. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31426393 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30952976
GET https://conductscience.org/api/papers/v1/30952976/references?page=2